Director dealings: Piers Morgan's spouse ups stake in Verona Pharma

Morgan's wife purchased the shares on Tuesday at an average price of 59p each, for a total value of £19,943.

Following the acquisition, Morgan will have a beneficial interest in the company of 147,009 ordinary shares, representing 0.14% of Verona's issued share capital, and takes the pair's total investment into the company over the last few months to £52,000.

Earlier in May, Verona announced the initiation of a phase 2b dose-ranging study evaluating nebulised ensifentrine (RPL554) added on to a long-acting bronchodilator in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) on Tuesday.

Verona told investors it anticipated reporting data around the end of the year, and beginning phase 3 clinical trials for the indication in 2020.

As of 1620 BST, Verona shares had slipped 2.96% to 57.25p.

Top Director Buys

General Electric Co (GEC)

Director name: Ms Risa Lavizzo-Mourey

Amount purchased: 10,000 @ 8.72

Value: 87,196

British Land Company (BLND)

Director name: Mr Chris Grigg

Amount purchased: 15,072 @ 534.68p

Value: £80,587

British Land Company (BLND)

Director name: Mr Simon Carter

Amount purchased: 7,774 @ 534.68p

Value: £41,566

Verona Pharma (VRP)

Director name: Mr Piers Morgan

Amount purchased: 33,802 @ 59.00p

Value: £19,943

Top Director Sells

Chesnara (CSN)

Director name: Mr David Rimmington

Amount sold: 26,800 @ 371.00p

Value: £99,428

Scottish Mortgage Inv Trust (SMT)

Director name: Professor Patrick Maxwell

Amount sold: 10,173 @ 511.00p

Value: £51,984

Whitbread (WTB)

Director name: Mr Louise Smalley

Amount sold: 232 @ 4,588.00p

Value: £10,644